Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-014511
Filing Date
2025-06-10
Accepted
2025-06-10 16:01:21
Documents
2
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1622
2 EX-24 ex24.htm EX-24 9930
  Complete submission text file 0001641172-25-014511.txt   13061
Mailing Address 27003 BARRINGTON LODGE LN KATY TX 77494
Business Address
Davis Jason (Reporting) CIK: 0001443533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41934 | Film No.: 251037005

Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)